Epigenetic silencing and pharmacological inhibition of EIF5A2 foster venetoclax sensitivity in acute myeloid leukaemia
Por:
Crespo-García, E, Quero-Dotor, C, Noguera-Castells, A, Sancho-Vila, L, Martinez-Verbo, L and Esteller, M
Publicada:
1 abr 2026
Ahead of Print:
1 ene 2026
Resumen:
Filiaciones:
:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Noguera-Castells, A:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Univ Vic Cent Univ Catalonia UV UCC, Fac Sci Technol & Engn, Dept Biosci, Vic, Barcelona, Spain
Sancho-Vila, L:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
Martinez-Verbo, L:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
:
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Cami Escoles S-N, Badalona 08916, Catalonia, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
Univ Barcelona UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Spain
St Pau Res Inst IRSantPau, Canc Epigenet Grp, Barcelona, Spain
Green Submitted, hybrid
|